DPP4 and diabetes mellitus: Nevertheless, this raised concern on potential harm all the more asanother trial EXAMINE conducted in patients with diabetes mellitus andpresenting with an acute coronary syndrome suggested a non-significant signalfor increased risk of heart failure with another DPP4 inhibitor, alogliptin(Table 1).3